U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436728) titled 'A Study of TAK-505 in Adults With Solid Tumors' on Feb. 05.
Brief Summary: Solid tumors occur when cells in an organ or tissue (for example in the lung or liver) start growing out of control (cancer) and form a lump or mass of cells. These solid cancers may grow very far in the general area where they started (called locally advanced) or may spread to other parts of the body (called metastatic), and doctors may not always be able to completely remove them with surgery (called unresectable).
This study is a first in human (or FIH) study, which means that this is the first time that the medicine, TAK-505, is given to a smaller group ...